Orange Grove Bio

Breaking medical barriers through university partnerships to accelerate drug development for treating cancer, autoimmune, and inflammatory diseases

[Orange Grove Bio @orangegrovebio]

“While Orange Grove Bio’s initial efforts have been focused on collaborating with universities and academic centers within the U.S., the reality is there are a broad array of excellent ex-US opportunities through which to pursue our model of harnessing medical technology innovation from markets beyond the traditional hubs of Boston and San Francisco. As we began to expand our thinking internationally, Yonsei University Health System and Pohang University of Science and Technology both immediately rose to the top of our list of priority targets,” said Marc Appel, Orange Grove Bio's chief executive officer.

#biotechnology #orangegrovebio #pressrelease #innovation #partnership

[Orange Grove Bio @orangegrovebio]

PRESS RELEASE - March 23, 2023: Orange Grove Bio expands academic collaboration activities internationally through new strategic partnerships with Yonsei University Health System and Pohang University of Science and Technology designed to strengthen biotech entrepreneurial ecosystem in South Korea.

With these latest academic collaborations, Orange Grove Bio is laying the foundation for serving as a bridge between the biotechnology industries in the U.S. and Korea. With this broadened, international reach, the firm aims to build innovative companies that combine capabilities from both countries and that are ultimately positioned to leverage the U.S. capital markets for financial support.

Full release linked below.

Read the full release to learn more: https://t.co/Or6uFXz3ej

[Orange Grove Bio @orangegrovebio]

Today we're launching our rebrand. As our business has grown, we have evolved. Our new look represents the expression of that journey and our next chapter. We might look different, but our mission remains the same. https://t.co/wrvJ2EIKcG #orangegrovebio #biotech #rebrand

[Orange Grove Bio @orangegrovebio]

This episode of From The Patient's Eyes is brought to you by Orange Grove Bio and the Autoimmune Registry to feature autoimmune patient Julianne Larkin as she shares her experiences as an individual diagnosed with Graves' disease and, later, arthritis. https://t.co/tvY2PGMrmd

[Orange Grove Bio @orangegrovebio]

We’re excited to announce the launch of the pilot episode of ‘From The Patient's Eyes,’ brought to you by Orange Grove Bio and the Autoimmune Registry to feature the story of Stephanie Giguere, a patient suffering from Ankylosing Spondylitis.

https://t.co/Iv8AX0AZMM

[Orange Grove Bio @orangegrovebio]

Just posted a photo https://t.co/HiBwyYgNhl

[Orange Grove Bio @orangegrovebio]

Check out this article written about our portfolio company @asalyxabio highlighting the findings of Asalyxa's CSO, @Lola_UMich

https://t.co/ZPPoOoF9Qn

[Orange Grove Bio @orangegrovebio]

Check out this piece about our portfolio company, Asalyxa Bio, in the Cronicle featuring our CEO, Marc Appel. https://t.co/Ul6MYMyXob

[Rare Disease Day @rarediseaseday]

Today is #RareDiseaseDay!

There are over 6⃣0⃣0⃣0⃣ rare diseases

🌏 300 million people live with a rare disease accross the world

Rare diseases currently affect 3.5% - 5.9% of the worldwide population👨‍👩‍👧‍👦

Learn more about what is a #raredisease

👉https://t.co/4axpDU3ofy

[Orange Grove Bio @orangegrovebio]

Proud to announce that our first portfolio company @asalyxabio has successfully raised seed funding and will now be headed to the clinic.
#clinicaltrials #Biotech

https://t.co/gxfmzFkJzp

[Orange Grove Bio @orangegrovebio]

Humbled to be featured in the WSJ. Looking forward to working with scientists on the forefront of biotech innovation. #wsj #Biotech #VentureCapital

https://t.co/AIwRsLIfja

[Orange Grove Bio @orangegrovebio]

On this Rare Disease Day, families just like the Harrisons are fighting to raise awareness for rare diseases that affect 300 million people across the world. To show your support, visit https://t.co/p6HN455wtB

https://t.co/k9S10dWazG

[Orange Grove Bio @orangegrovebio]

Listen to our founder Marc Appel speak about innovation and driving factors in the biotech industry with Mark Bayer, link is in our bio. https://t.co/llj3Ka125t

[bradweinberg @bradweinberg]

Been recently following what Marc Appel and team is creating at Orange Grove Bio. Recently started trial for their first drug candidate with more to come. https://t.co/ZLllvXhcS2 @GroveBio

[Innovation Partnerships @INNOVPARTNER]

The @GroveBio release: https://t.co/8EMPDBU1dP

[Innovation Partnerships @INNOVPARTNER]

Happy to announce the launch of @UMichChE professor Lola Eniola-Adefeso's new @UMich startup Asalyxa Bio to advance her potential therapy for Acute Respiratory Distress Syndrome (#ARDS), the leading cause of death among #COVID19 patients. @GroveBio

https://t.co/t7D8fG4AQt

[Orange Grove Bio @orangegrovebio]

We have some big news coming this week... stay tuned to find out!

[Ten Bridge Communications @TenBridge]

The New Yorker takes a peek inside B.U.'s National Emerging Infectious Diseases Laboratories, a hub for coordinating coronavirus research: https://t.co/DsBrYv8Qwx

[Moderna @moderna_tx]

We just announced the publication of a nonhuman primate preclinical viral challenge study of mRNA-1273 in @NEJM. Read more: https://t.co/5xE2gjC05P

[Novavax @Novavax]

With the aid of Operation Warp Speed funding, #NVAX is committed to delivering 100 million doses of our #vaccine candidate starting by the end of the year. Thank you to
@FujifilmDiosyn for hosting us with @Potus and members of the administration today. $NVAX #NVXCoV2373